|
| Date |
Type |
Title |
|
Jun 07, 2005 |
Article |
Potential for Reducing the Progression of Alzheimer's Revealed
University of Florida researchers have discovered a way to reduce plaque deposits on the brain that could slow the progression of Alzheimer's disease. |
|
May 23, 2005 |
Article |
National Institute on Aging Awards UCI $9 Million to Continue Alzheimer's Disease Research
New research projects include the study of age-related changes in the brain and the role of mitochondrial defects in causing Alzheimer’s. |
|
Apr 27, 2005 |
Article,DrugNews |
New Drug Program Helps More Than 100,000 Patients in First Three Weeks
A new program that helps patients in need get prescription medicines is generating an outpouring of inquiries from patients nationwide. |
|
Apr 25, 2005 |
Article |
Alzheimer's Cognitive Decline Slowed in UCSD Study
PET scans and cognitive tests have suggested that Alzheimer's disease patients with genetically modified tissue inserted directly into their brains show a reduction in the rate of cognitive decline and increased metabolic activity in the brain, according to a study published in the April 24, 2005 online issue of the journal Nature Medicine by researchers at the University of California, San Diego (UCSD) School of Medicine. |
|
Apr 25, 2005 |
Article |
New Weapon Against Alzheimer's Found
Regular infusions of plasma-derived antibodies appear to reduce levels of Alzheimer's disease-causing brain plaques while improving patients' thinking ability, researchers report. |
|
Apr 18, 2005 |
Article |
Alzheimer’s Disease Research Study Clinical Research Associates® Seeking Volunteers for Alzheimer's Clinical Study
Alzheimer’s Disease Research Study Clinical Research Associates® is seeking volunteers with Alzheimer’s disease (AD), and their caregivers, to participate in a clinical research study. |
|
Apr 01, 2005 |
Article,DrugNews |
FDA MedWatch: Reminyl (galantamine) Precautions Due to Deaths Reported in Clinical Trials
Ortho-McNeil Neurologics modified the PRECAUTIONS section of the Prescribing Information for Reminyl, approved only for the treatment of mild to moderate Alzheimer's Disease. The changes provide new safety information regarding the results of two randomized, placebo-controlled trials of 2 years duration in subjects with mild cognitive impairment(MCI). |
|
Mar 25, 2005 |
Article |
Alzheimer's Documentary Airs Nationwide March 28
Half-hour TV Special on ABC Family Channel Urges Early Diagnosis for Patients, Plus Respite and Support for Caregivers |
|
Feb 28, 2005 |
Article |
Neuronal Traffic Jam Marks Early Alzheimer's
Early Alzheimer's disease may be precipitated by a “traffic jam” within neurons that causes swelling and prevents proper transport of proteins and structures in the cells, according to new studies by Howard Hughes Medical Institute researchers. |
|
Feb 24, 2005 |
Article,DrugNews |
Quetiapine speeds up rate of decline in Alzheimers?
Quetiapine, a drug commonly used in nursing homes to treat agitation and related symptoms in people with Alzheimers' disease actually worsens patients' illness, speeding up their rate of decline significantly, says a paper published on bmj.com. |
|
|
Next 10 Articles>> |
|
|
|
